AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05518240 — intervention group
Intervention type: DEVICE
Intervention: Stent Retrievers
Description: Procedure: Embotrap device
Study NCT05518240 — intervention group
Intervention type: DEVICE
Intervention: Stent Retriever
Description: Procedure: Solitaire device
Study NCT04813575 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cryo lung biopsies
Description: Bronchoscopic lung biopsy utilizing the cryo technique
Study NCT06303583 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paclitaxel
Description: paclitaxel, 50 mg/m2, QW\*5
Study NCT06303583 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin
Description: area under the curve of2mg/mL/min, QW\*5
Study NCT06303583 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tislelizumab
Description: 200mg Q3W, 2cycles
Study NCT06482190 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RSN0402 Part 1
Description: Participants will receive single ascending doses of 2mg, 4mg, 8mg, 12 mg, and 16mg of RSN0402 or placebo on Day 1 for Cohort 1 to 5. Cohort 2(4mg) will also a single dose of 150 mg nintedanib soft capsule will be administered orally after at least 7-days washout period.
Study NCT06482190 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RSN0402 Part 2
Description: Participants will receive multiple ascending doses of 4mg ,8mg,12mg ,16mg of RSN0402 or placebo administered once daily from Day 1 to Day 7 for Cohort 6 to 9.
Study NCT06482190 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive matching placebo across Part 1 and Part 2 of the study.
Study NCT05704998 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Description: Posture exercises, myofascial release techniques, sternocleidomastoideus and upper trapezius kinesio taping, trigger point ischemic compression, suboccipital release technique, cervical traction, deep neck flexors endurance exercises, massage
Study NCT06129435 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Visuospatial Task (VST)
Description: Participants randomized to the VST condition will play a visuospatial game (i.e., Tetris). Participants will be given two minutes to practice Tetris and then will be instructed to play for 15 minutes without stopping.
Study NCT06129435 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Word Association Task (WAT)
Description: Participants randomized to the WAT condition will play a word association game. Research staff members will read from a list of 300 words, not associated with trauma, to the participant. The participant will verbally respond to each word out loud with the first word that comes to their mind. This word association task will continue for 15 minutes or until all 300 words are read, whichever occurs first.
Study NCT06303583 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiotherapy
Description: 41.4Gy in 23 fractions
Study NCT04951128 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid injection
Description: Tranexamic acid (100 mg/mL concentration; 0.5 mL) will be added to local anesthetic mixture of 2% lidocaine with epinephrine (2.25 mL) and 0.5% bupivacaine with epinephrine (2.25mL).
Study NCT04951128 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Local anesthetic control
Description: Local anesthetic mixture without tranexamic acid consisting of 2% lidocaine with epinephrine (2.5 mL) and 0.5% bupivacaine with epinephrine (2.5 mL).
Study NCT04783363 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Snoezelen session
Description: before one of two repeated invasive care
Study NCT06451536 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Ga-68 FAPI PET/CT
Description: imaging of FAP expression of tumor before immunotherapy
Study NCT05354856 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indocyanine green
Description: A bolus of ICG (0.2 mg/kg body weight) will be injected intravenously and flushed with 5 mL of saline. Gastric perfusion will subsequently be assessed along specific regions of interest (ROI) with q-ICG (quantitative perfusion assessments with ICG) to obtain baseline perfusion values.
Study NCT05690607 — intervention group
Intervention type: OTHER
Intervention: Doctors Laboratory TINIES small volume blood testing kit
Description: Doctors Laboratory TINIES small volume blood testing kits comprise microcontainers manufactured by BD Diagnostics designed for sample collection from skin puncture, along with home testing pack with lancets, instructions and Royal Mail postal packs.
Study NCT05892757 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atogepant
Description: Oral Tablet
Study NCT05892757 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ubrogepant
Description: Oral Tablet
Study NCT06197438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Tislelizumab will be administered on day 1 of each cycle at 200mg once every 21 days.
Study NCT06197438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Oxaliplatin will be administered on day 1 of each cycle at 85mg/m2 once every 14 days.
Study NCT06197438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levo-Leucovorin
Description: Levo-Leucovorin will be administered on day 1 of each cycle at 200 mg/m2 once every 14 days.
Study NCT06197438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil
Description: 5-fluorouracil will be administered at 2400 mg/m2 over 46-hour every 14 days.
Study NCT06197438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan Hydrochloride
Description: Irinotecan will be administered on day 1 of each cycle at 135 mg/m2 once every 14 days.
Study NCT06197438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Paclitaxel will be administered on day 1 of each cycle at 90 mg/m2 once every 14 days.
Study NCT05229159 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Bioelectrical impedance analysis
Description: Segmental multi-frequency bioelectrical impedance analysis are carried out at all patient admitted to our ICU for postoperative care after cardiac surgery with cardiopulmonary bypass. Our objective is to evaluate the relevance of phase angle to predict mortality or a prolonged hospital length of stay. Phase angle is evaluated at ICU admission and will be compared to well-known prognostic scores computed in preoperative (EuroSCORE II) and at day one after surgery (SOFA, CASUS and SAPS II).
Study NCT06416891 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bupivacaine 0.25%
Description: SCPB using 10 ml of bupivacaine 0.25%
Study NCT06416891 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dexamethasone 2 mg in bupivacaine 0.25%
Description: SCPB using dexamethasone 2 mg in 10 ml of bupivacaine 0.25%
Study NCT06532318 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Platelet rich plasma
Description: Freshly prepared autologus platelet rich plasma
Study NCT06532318 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pfizer Depo-medrol
Description: Methylprednisolone acetate 20mg/ml injection
Study NCT05673421 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exergaming Training
Description: VR game-assisted intervention will perform for 30-45 min, 5 sessions per week for a duration of 8 weeks
Study NCT05673421 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Visual Feedback Training
Description: During the visual feedback practices, patients will be seated or in a standing phase close to a table on which a mirror would be placed vertically. The practice would be consisted of nonparetic-side shoulder, elbow, wrist and finger flexion, extension, abduction, adduction movements, task oriented activities like, unscrewing lid of jar ,card stacking, moving coins or marbles from one box to another, Folding towels and stacking them, picking glass, while patient will look into the mirror, -watching the image of their noninvolved hand, thus seeing the reflection of the hand movement projected over the involved hand. After watching the practices on the uninvolved side, patient will be asked to try to do the same movements with the paretic limb while they will be moving the nonparetic limb.Each activity will be performed for 4 min, with a 1 min preparation time between tasks.
Study NCT05006937 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dusting
Description: Dusting is when a laser is used to break a stone down into tiny fragments that are able to pass through the urine.
Study NCT05006937 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Basket extraction
Description: Basket extraction is when a small wire basket is used to remove stone fragments.
Study NCT05738356 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Adhesive bonding systems
Description: Three different adhesive bonding systems were used; one system per group
Study NCT05738356 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Adhesive bonding systems
Description: Three different adhesive bonding systems were used; one system per group
Study NCT05325892 — intervention group
Intervention type: COMBINATION_PRODUCT
Intervention: This is an observational study
Description: This is an observational study
Study NCT06057285 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: An ACLs cart training course was developed using augmented reality (AR) technologies
Description: The developed first aid cart learning system was applied to ACLs drills in a regular ACLs training program, and an AR group used this learning system to assist in their learning. The AR group scanned the dedicated AR marker using a mobile device
Study NCT06366256 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Traditional ultrasound biofeedback
Description: Participants use a B-mode ultrasound device to view their tongue movement on a screen. The participant sees the ultrasound image of their tongue moving in sagittal plane on the screen. The speech-language pathologist working with the participant also views participant's tongue movement and provides verbal instruction on how the participant should move their tongue to produce a perceptually correct r sound in simple syllables (CV, VC), as well as evaluative statements about accuracy. Participants practice moving their tongue along with these instructions, practicing the simple syllable (CV, VC) words.~VC=vowel consonant syllables (ex. or) CV=consonant vowel syllables (ex. ra)
Study NCT06366256 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Simplified ultrasound biofeedback
Description: Participants use a B-mode ultrasound device that captures the movement of their tongue and software that transforms the movement of their tongue into gamified objects on a screen. The participant sees a game object (a character) move on the screen towards goals; the movement of the game object represents the movement of the tongue and the goals are representative of tongue movements that correlate with an acoustic percept of accuracy. The speech-language pathologist working with the participant views the movement of the game object and provides verbal instruction on how the participant should move the game character in order to reach the goals when saying simple syllable words (CV, VC) as well as evaluative statements about accuracy. Participants practice moving their tongue along with these instructions, practicing the simple syllable (CV, VC) words.~VC=vowel consonant syllables (ex. or) CV=consonant vowel syllables (ex. ra)
Study NCT06286553 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Trunk exercise
Description: Trunk stabilization exercises including the following components: (a) progressive deep abdominal muscle retraining (transversus abdominis), (b) progressive pelvic floor muscle retraining, (c) abdominal muscle strengthening exercises (rectus abdominis and obliques), (d) combination of abdominal muscle control and distal extremity movements, and (e) progressive functional exercises.
Study NCT06286553 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Trunk exercise
Description: Trunk stabilization exercises including the following components: (a) progressive deep abdominal muscle retraining (transversus abdominis), (b) progressive pelvic floor muscle retraining, (c) abdominal muscle strengthening exercises (rectus abdominis and obliques), (d) combination of abdominal muscle control and distal extremity movements, and (e) progressive functional exercises.
Study NCT06286553 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Description: Inspiratory muscle strengthening exercises using inspiratory resistance (IMT devices)
Study NCT06286553 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: Participants in the Control Group will receive general management information for DRA, written instructions and a single educational exercise session for contracting the deeper abdominals and pelvic floor muscles.
Study NCT06546683 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Short-Chain Fatty Acids
Description: Colon-delivery capsules of Short-Chain Fatty Acids will be administered in a ratio of 60:20:20, thus 150 mmol of acetate, 50 mmol of propionate and 50 mmol of butyrate equivalent to 20g of fibers, once daily, one week
Study NCT06546683 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Microcrystalline Cellulose will be used as placebo, one daily, one week
Study NCT04836156 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for triple negative breast cancer
Description: The choice of chemotherapy is based on the PTC drug sensitivity results.
Study NCT04836156 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for luminal like breast cancer
Description: The choice of chemotherapy is based on the PTC drug sensitivity results.
Study NCT05174299 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: magnetic stimulation
Description: For Experimental Arm, active magnetic stimulation on motor cortex followed by active magnetic stimulation on spinal cord, patients underwent ten sessions of double active magnetic stimulation with low frequency repetitive transcranial magnetic stimulation (rTMS) over the bilateral primary motor cortex of the lower leg followed by low frequency repetitive magnetic stimulation over the spinal cord. For Active Comparator Arm, active magnetic stimulation on motor cortex followed by sham magnetic stimulation on spinal cord. For Sham Comparator Arm, sham magnetic stimulation on motor cortex followed by sham magnetic stimulation on spinal cord.
Study NCT05174299 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: magnetic stimulation
Description: For Experimental Arm, active magnetic stimulation on motor cortex followed by active magnetic stimulation on spinal cord, patients underwent ten sessions of double active magnetic stimulation with low frequency repetitive transcranial magnetic stimulation (rTMS) over the bilateral primary motor cortex of the lower leg followed by low frequency repetitive magnetic stimulation over the spinal cord. For Active Comparator Arm, active magnetic stimulation on motor cortex followed by sham magnetic stimulation on spinal cord. For Sham Comparator Arm, sham magnetic stimulation on motor cortex followed by sham magnetic stimulation on spinal cord.
Study NCT05174299 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: magnetic stimulation
Description: For Experimental Arm, active magnetic stimulation on motor cortex followed by active magnetic stimulation on spinal cord, patients underwent ten sessions of double active magnetic stimulation with low frequency repetitive transcranial magnetic stimulation (rTMS) over the bilateral primary motor cortex of the lower leg followed by low frequency repetitive magnetic stimulation over the spinal cord. For Active Comparator Arm, active magnetic stimulation on motor cortex followed by sham magnetic stimulation on spinal cord. For Sham Comparator Arm, sham magnetic stimulation on motor cortex followed by sham magnetic stimulation on spinal cord.
Study NCT06386757 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Combined Video Laryngoscopy (VL) and Bougie
Description: To compare combined video laryngoscopy and bougie versus direct laryngoscopy and bougie for nasal intubation.
Study NCT04735237 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Autogenous fat injection
Description: Done under general anesthesia. Fat is to be harvested from the abdomen using manual liposuction. Small aliquots of fat are to be injected into the philtral column (and in the vermilion and any other area of volume insufficiency if needed).
Study NCT04735237 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgical revision with orbicularis oris muscle reconstruction.
Description: Surgical repair done under general anesthesia. The original scar will be marked on the skin with methylene blue. The skin will be incised along the designed line with scar removal. The orbicularis oris muscle stump will be dissected medially and laterally and approximated by means of 4-0 inverted horizontal mattress sutures.
Study NCT06386757 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Combined Direct Laryngoscopy (DL) and Bougie
Description: To compare combined video laryngoscopy and bougie versus direct laryngoscopy and bougie for nasal intubation
Study NCT04818580 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Progressive Tension Sutures
Description: In each patient, one side of the chest will receive progressive tension sutures inside the mastectomy pocket, from pectoral fascia to underside of mastectomy flap. 2-0 Vicryl about 15-20 sutures per chest. Both sides will receive bilateral drains (standard of care)
Study NCT04818580 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Progressive Tension Sutures
Description: In each patient, one side of the chest will receive progressive tension sutures inside the mastectomy pocket, from pectoral fascia to underside of mastectomy flap. 2-0 Vicryl about 15-20 sutures per chest. Both sides will receive bilateral drains (standard of care)
Study NCT04844749 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VERU-111
Description: Based on the safety and antitumor activity of VERU-111 in the Phase 1b/2 clinical study, VERU-111 is initiating this Phase 3 clinical study of VERU-111 for the treatment of metastatic castration resistant prostate cancer in patients who have failed prior treatment with at least one androgen receptor targeting agent
Study NCT04844749 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Enzalutamide, Abiraterone
Description: Enzalutamide and abiraterone were chosen as active comparators are both are FDA approved for the treatment of metastatic castration resistant prostate cancer
Study NCT05410600 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Arm ergometer smart trainer cycling program
Description: Arm ergometer exercise training using the smart trainer.
Study NCT05391854 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Pep2dia
Description: 700 mg Pep2Dia® 15 min prior to breakfast and 700 mg Pep2Dia® 15 min prior to dinner
Study NCT05391854 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 700 mg placebo 15 min prior to breakfast and 700 mg placebo 15 min prior to dinner
Study NCT05095610 — intervention group
Intervention type: DEVICE
Intervention: Flash
Description: Use of the device FreeStyle Libre, only commercialized system for intermitent continuous glucose monitoring.
Study NCT04803981 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SpoonfulONE
Description: SpoonfulONE is a line of nutritional food products designed to help improve diet diversity starting in early infancy. SpoonfulONE covers a wide range of food proteins. Each product contains 30 mg of peanuts, milk, shellfish (shrimp), tree nuts (almond, cashew, hazelnut, pecan, pistachio, and walnut), egg, fish (cod and salmon), grains (wheat and oat), soy, and sesame.
Study NCT05830162 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: We will evaluate how many women gets an infection and/or wound dehiscence after a second degree obstetric tear or episiotomy
Study NCT05830162 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bioclavid (Amoxicillin and Clavulanic acid)
Description: We will evaluate how many women gets an infection and/or wound dehiscence after a second degree obstetric tear or episiotomy
Study NCT06526117 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Description: The study intervention will include initial treatment with low-dose hydroxyurea therapy at 10 mg/kg/day (range 7 - 15 mg/kg/day), with subsequent increase to moderate dose hydroxyurea therapy at 20 mg/kg/day (range 17.5 - 26 mg/kg/day) after at least two severe events requiring physician contact.
Study NCT06523530 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Goserelin Acetate 3.6 mg inj, implant
Description: 3.6 mg (1ml) administered subcutaneously once every month for 6 months (totally 6 injections)
Study NCT05671874 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Web/mobile/tablet-based digital decision aid + communication (DA+C) tool
Description: The web/mobile/tablet-based digital DA+C toll is designed to enhance communication and shared decision making between clinicians and surrogates of critically ill severe acute brain injury (SABI) with four goals: to 1) prepare families for their surrogate role and discussions with clinicians; 2) provide balanced information to families on prognosis and all available treatment options; 3) provide tailored information about the patient and family to clinicians in advance of family meetings; and 4) serve as a communication guide for clinicians in the clinician-family meeting to facilitate shared decision-making.